These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 33298940)

  • 1. Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson's disease.
    Fričová D; Korchak JA; Zubair AC
    NPJ Regen Med; 2020 Nov; 5(1):20. PubMed ID: 33298940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mesenchymal stem cell on dopaminergic neurons, motor and memory functions in animal models of Parkinson's disease: a systematic review and meta-analysis.
    Park JM; Rahmati M; Lee SC; Shin JI; Kim YW
    Neural Regen Res; 2024 Jul; 19(7):1584-1592. PubMed ID: 38051903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells and neuroregeneration in Parkinson's disease.
    Glavaski-Joksimovic A; Bohn MC
    Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report.
    Vij R; Prossin A; Tripathy M; Kim H; Park H; Cheng T; Lotfi D; Chang D
    Front Neurol; 2023; 14():1257080. PubMed ID: 37840944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.
    Sonntag KC; Song B; Lee N; Jung JH; Cha Y; Leblanc P; Neff C; Kong SW; Carter BS; Schweitzer J; Kim KS
    Prog Neurobiol; 2018 Sep; 168():1-20. PubMed ID: 29653250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of Mesenchymal Stem Cells as a Multitarget Disease- Modifying Therapy for Parkinson's Disease.
    Unnisa A; Dua K; Kamal MA
    Curr Neuropharmacol; 2023; 21(4):988-1000. PubMed ID: 35339180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intranasal stem cell administration on the nigrostriatal system in a mouse model of Parkinson's disease.
    Salama M; Sobh M; Emam M; Abdalla A; Sabry D; El-Gamal M; Lotfy A; El-Husseiny M; Sobh M; Shalash A; Mohamed WM
    Exp Ther Med; 2017 Mar; 13(3):976-982. PubMed ID: 28450929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretome as neuropathology-targeted intervention of Parkinson's disease.
    Ardianto C; Shen R; Barus JFA; Sasmita PK; Turana Y; Lilis L; Sidharta VM
    Regen Ther; 2022 Dec; 21():288-293. PubMed ID: 36092507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell Therapy for Parkinson's Disease.
    Shastry S; Hu J; Ying M; Mao X
    Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38139997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update on Human Stem Cell-Based Therapy in Parkinson's Disease.
    González C; Bonilla S; Flores AI; Cano E; Liste I
    Curr Stem Cell Res Ther; 2016; 11(7):561-8. PubMed ID: 26027681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospective role of mesenchymal stem cells in Parkinson's disease.
    Tambe P; Undale V; Sanap A; Bhonde R; Mante N
    Parkinsonism Relat Disord; 2024 Aug; ():107087. PubMed ID: 39142905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.
    Sarkar S; Raymick J; Imam S
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment.
    Heris RM; Shirvaliloo M; Abbaspour-Aghdam S; Hazrati A; Shariati A; Youshanlouei HR; Niaragh FJ; Valizadeh H; Ahmadi M
    Stem Cell Res Ther; 2022 Jul; 13(1):371. PubMed ID: 35902981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease.
    Hoban DB; Howard L; Dowd E
    Neuroscience; 2015 Sep; 303():402-11. PubMed ID: 26166730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of stem cell-based therapies for Parkinson's disease.
    Zhu B; Caldwell M; Song B
    Int J Neurosci; 2016 Nov; 126(11):955-62. PubMed ID: 26824870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Transplantation of Adipose-Derived Mesenchymal Stem Cells Promoted The Production of Dopaminergic Neurons and Improved Spatial Memory in A Rat Model of Parkinson's Disease.
    Hamedi H; Ghorbanian SH; Mirzaeian L; Abrari K; Mozdziak P; Ghorbanian MT
    Cell J; 2023 May; 25(5):317-326. PubMed ID: 37300293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies to address mesenchymal stem/stromal cell heterogeneity in immunomodulatory profiles to improve cell-based therapies.
    Dunn CM; Kameishi S; Grainger DW; Okano T
    Acta Biomater; 2021 Oct; 133():114-125. PubMed ID: 33857693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.